Twist Bioscience (TWST) Free Cash Flow (2017 - 2026)

Twist Bioscience has reported Free Cash Flow over the past 10 years, most recently at -$13.1 million for Q1 2026.

  • Quarterly Free Cash Flow fell 7.77% to -$13.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$87.8 million through Mar 2026, down 45.35% year-over-year, with the annual reading at -$75.6 million for FY2025, 9.34% down from the prior year.
  • Free Cash Flow was -$13.1 million for Q1 2026 at Twist Bioscience, up from -$34.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $3.9 million in Q3 2023 and troughed at -$74.8 million in Q2 2022.
  • The 5-year median for Free Cash Flow is -$23.6 million (2024), against an average of -$29.6 million.
  • Year-over-year, Free Cash Flow soared 122.05% in 2023 and then plummeted 543.02% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$65.9 million in 2022, then skyrocketed by 62.85% to -$24.5 million in 2023, then increased by 3.74% to -$23.6 million in 2024, then crashed by 47.63% to -$34.8 million in 2025, then skyrocketed by 62.27% to -$13.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Free Cash Flow are -$13.1 million (Q1 2026), -$34.8 million (Q4 2025), and -$24.2 million (Q3 2025).